Comprehensive molecular profiling of FLT3-mutated acute myeloid leukemia (AML) patients treated within the RATIFY trial (Alliance C10603) Meeting Abstract


Authors: Jahn, N.; Panina, E.; Bullinger, L.; Dolnik, A.; Herzig, J.; Blätte, T. J.; Benner, A.; Krzykalla, J.; Gathmann, I.; Larson, R. A.; Lo-Coco, F.; Amadori, S.; Prior, T. W.; Brandwein, J. M.; Appelbaum, F. R.; Medeiros, B. C.; Tallman, M. S.; Tiecke, E.; Pallaud, C.; Ehninger, G.; Heuser, M.; Ganser, A.; Stone, R. M.; Thiede, C.; Döhner, H.; Bloomfield, C. D.; Döhner, K.
Abstract Title: Comprehensive molecular profiling of FLT3-mutated acute myeloid leukemia (AML) patients treated within the RATIFY trial (Alliance C10603)
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837604205
PROVIDER: wos
DOI: 10.1182/blood-2018-99-115842
Notes: Meeting Abstract: 1534 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman